Literature DB >> 2157055

Mutation of the serine 312 phosphorylation site does not alter the ability of mouse p53 to inhibit simian virus 40 DNA replication in vivo.

D W Meek1, W Eckhart.   

Abstract

Two mutations were introduced into the wild-type mouse p53 gene by oligonucleotide-directed mutagenesis. These mutations substituted alanine or aspartic acid for serine at position 312, which is constitutively phosphorylated. Phosphopeptide mapping of the mutant proteins, expressed in COS cells, confirmed the loss of phosphorylation at position 312. There were no changes in the ability of the mutant p53s to express the conformation-dependent epitope for monoclonal antibody PAb246 or to participate in complexes with the simian virus 40 (SV40) large T antigen. Replication of a plasmid containing the SV40 origin of replication was inhibited in COS cells by wild-type p53 and both of the phosphorylation site mutants with equal efficiency. A transforming mutant of p53, encoding valine at position 135, did not inhibit SV40 DNA replication in COS cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2157055      PMCID: PMC249311          DOI: 10.1128/JVI.64.4.1734-1744.1990

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  79 in total

1.  Antigenic binding sites of monoclonal antibodies specific for simian virus 40 large T antigen.

Authors:  E G Gurney; S Tamowski; W Deppert
Journal:  J Virol       Date:  1986-03       Impact factor: 5.103

2.  Monoclonal antibody analysis of p53 expression in normal and transformed cells.

Authors:  J W Yewdell; J V Gannon; D P Lane
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

3.  The use of phosphorothioate-modified DNA in restriction enzyme reactions to prepare nicked DNA.

Authors:  J W Taylor; W Schmidt; R Cosstick; A Okruszek; F Eckstein
Journal:  Nucleic Acids Res       Date:  1985-12-20       Impact factor: 16.971

4.  The rapid generation of oligonucleotide-directed mutations at high frequency using phosphorothioate-modified DNA.

Authors:  J W Taylor; J Ott; F Eckstein
Journal:  Nucleic Acids Res       Date:  1985-12-20       Impact factor: 16.971

5.  Overproduction of p53 antigen makes established cells highly tumorigenic.

Authors:  D Eliyahu; D Michalovitz; M Oren
Journal:  Nature       Date:  1985 Jul 11-17       Impact factor: 49.962

6.  Mapping of phosphomonoester and apparent phosphodiester bonds of the oncogene product p53 from simian virus 40-transformed 3T3 cells.

Authors:  A Samad; C W Anderson; R B Carroll
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

7.  Identification of the p53 protein domain involved in formation of the simian virus 40 large T-antigen-p53 protein complex.

Authors:  T H Tan; J Wallis; A J Levine
Journal:  J Virol       Date:  1986-09       Impact factor: 5.103

8.  The cellular oncogene p53 can be activated by mutagenesis.

Authors:  J R Jenkins; K Rudge; P Chumakov; G A Currie
Journal:  Nature       Date:  1985 Oct 31-Nov 6       Impact factor: 49.962

9.  Replacement of insulin receptor tyrosine residues 1162 and 1163 compromises insulin-stimulated kinase activity and uptake of 2-deoxyglucose.

Authors:  L Ellis; E Clauser; D O Morgan; M Edery; R A Roth; W J Rutter
Journal:  Cell       Date:  1986-06-06       Impact factor: 41.582

10.  Genetic mapping of a major site of phosphorylation in adenovirus type 2 E1A proteins.

Authors:  A S Tsukamoto; A Ponticelli; A J Berk; R B Gaynor
Journal:  J Virol       Date:  1986-07       Impact factor: 5.103

View more
  12 in total

1.  Protein kinase CK2-dependent regulation of p53 function: evidence that the phosphorylation status of the serine 386 (CK2) site of p53 is constitutive and stable.

Authors:  L McKendrick; D Milne; D Meek
Journal:  Mol Cell Biochem       Date:  1999-01       Impact factor: 3.396

2.  Mutation of the casein kinase II phosphorylation site abolishes the anti-proliferative activity of p53.

Authors:  D M Milne; R H Palmer; D W Meek
Journal:  Nucleic Acids Res       Date:  1992-11-11       Impact factor: 16.971

Review 3.  Nuclear protein phosphorylation and growth control.

Authors:  D W Meek; A J Street
Journal:  Biochem J       Date:  1992-10-01       Impact factor: 3.857

4.  Activities and response to DNA damage of latent and active sequence-specific DNA binding forms of mouse p53.

Authors:  Y Wu; H Huang; Z Miner; M Kulesz-Martin
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

5.  Simian virus 40 can overcome the antiproliferative effect of wild-type p53 in the absence of stable large T antigen-p53 binding.

Authors:  D Michael-Michalovitz; F Yehiely; E Gottlieb; M Oren
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

6.  Phosphorylation sites in the amino-terminal region of mouse p53.

Authors:  Y Wang; W Eckhart
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

7.  Murine p53 inhibits the function but not the formation of SV40 T antigen hexamers and stimulates T antigen RNA helicase activity.

Authors:  P N Friedman; E H Wang; K Meerovitch; N Sonenberg; C Prives
Journal:  Chromosoma       Date:  1992       Impact factor: 4.316

8.  p53 is covalently linked to 5.8S rRNA.

Authors:  B M Fontoura; E A Sorokina; E David; R B Carroll
Journal:  Mol Cell Biol       Date:  1992-11       Impact factor: 4.272

9.  Human DNA-activated protein kinase phosphorylates serines 15 and 37 in the amino-terminal transactivation domain of human p53.

Authors:  S P Lees-Miller; K Sakaguchi; S J Ullrich; E Appella; C W Anderson
Journal:  Mol Cell Biol       Date:  1992-11       Impact factor: 4.272

10.  Altered phosphorylation of free and bound forms of monkey p53 and simian virus 40 large T antigen during lytic infection.

Authors:  L C Tack; J H Wright
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.